LSE:AZNPharmaceuticals
Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its Strong Five Year Run?
If you are wondering whether AstraZeneca shares still offer value after a strong run, this article walks through what the current price really implies.
The stock last closed at £135.12, with returns of 27.8% over 1 year and 94.1% over 5 years, alongside shorter term moves of a 3.2% decline over 7 days, an 11.8% decline over 30 days, and a 0.6% decline year to date.
Recent coverage has focused on AstraZeneca's role as a major pharmaceuticals group listed in London and how market expectations...